SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as the community highlights its recent partnership with bitcoin.com, anticipating increased attention and adoption of its privacy-focused, compliance-ready blockchain. Discussions revolve around Concordium's potential to lead in PayFi and its infrastructure play for real-world applications, with some suggesting it's undervalued and positioned for significant growth.

P8BCI Is the CCM Creator Capital Markets Creator token created by Nick Wray, intended to form a community for talking about his journey with ALS, his experiences with Telepathy BCI experiments, as well as his experiences and journey through the Solana blockchain, and cryptocurrency world of Web 3. In addition to this, prior to his progression of ALS Nick was an avid drummer, a creative, and an enjoyer of philosophical discussion - and enabled now by his BCI explores creating, and in addition to sharing his story, interacting with the community forming around his experiences.

Telepath8

Telepath8 is gaining attention as the community highlights the developer's innovative approach and technology. The connection between the developer and a prominent figure in the tech world is a key talking point. The project is receiving increased interest due to its unique development process.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending as investors discuss its massive cash reserves and potential investment strategies amid broader market concerns. Community members are analyzing recent earnings, potential buybacks, and comparing it to high-growth tech stocks. There's also speculation around potential acquisitions, particularly in energy and undervalued sectors.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap ($UNI) is trending as the community discusses its potential for growth, driven by high annualized fees and strong fundamentals. The recent launch of the Ethereum Protocol Advocacy Alliance, aimed at shaping crypto regulation, is also sparking interest. Traders are closely watching for breakout opportunities and fee-sharing developments.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as crypto enthusiasts discuss its potential amid a recent surge, drawing comparisons to Zcash's impressive run. Community members are actively debating entry points, dip-buying strategies, and long-term prospects, while highlighting ICP's underlying technology and recent developments like Caffeine AI as potential catalysts. The conversation reflects a mix of bullish sentiment and caution, with some anticipating further upward momentum and others suggesting a possible pullback.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as traders assess recent market volatility and the potential impact of the ongoing government shutdown. Community discussions revolve around technical indicators, with some anticipating a downturn while others remain bullish, citing seasonal factors. Additionally, Berkshire Hathaway's AI initiatives have sparked interest, with some viewing the stock as undervalued.

Monero

Monero is trending as discussions swirl around its use as a privacy coin and community members express excitement over recent price movements. Some believe it will be a key player in a future digital landscape, with a few referencing its potential for high returns. The coin's strong privacy features continue to be a key point, with some anticipating increased adoption as users seek alternatives to more transparent cryptocurrencies.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors weigh its performance amid broader market dynamics and AI-related discussions. Community chatter includes the company's massive cash position and speculation on potential buybacks or acquisitions, especially as Buffett's CEO transition approaches. Discussions also cover Berkshire's potential as a safe haven amid market uncertainty.

SSgA Active Trust - Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund

XLV is trending as traders discuss potential breakout patterns and whether the healthcare sector is poised to challenge all-time highs. Bullish sentiment is fueled by rising A/D Line and MFI, suggesting accumulation by institutions, while some analysts point to attractive valuations relative to the broader market. Community members are actively monitoring technical formations like bullish pendants and head and shoulders patterns to gauge future price movement.

Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.

Axcelis Technologies Inc

Axcelis Technologies ($ACLS) is trending due to analyst upgrades and positive sentiment around its role in semiconductor manufacturing, especially for silicon carbide (SiC) applications in EVs and AI. Community discussions highlight its strong fundamentals, earnings beats, and potential for a significant merger, driving speculation about future growth and stock performance. Recent news of partnerships and shipments to key industry players are also contributing to the buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fossil Group (FOSL) shares were down nearly 39% in premarket trading on Thursday morning after the company said on Thursday that it has further extended the&nbsp;expiration of the exchange offer concerning its 7.00% Senior Notes due 2026.The company also noted that it has extended the consent solicitation and its concurrent rights offering from October 15 to October 22.Separately, the company stated that it is not currently pursuing an initial public offering of its subsidiary in India, following recent media reports about the subsidiary going public.Retail sentiment on Fossil Group jumped to ‘extremely bullish’ from ‘bearish’ territory a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.On Wednesday, Fossil Group’s shares had closed up 41.5% at a two-and-a-half-year high of $3.75 following the news of the IPO of its Indian unit. According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-15/fossil-india-is-said-to-weigh-ipo-that-could-raise-400-million">Bloomberg News report</a>, Fossil India was in talks to raise $300 million to $400 million by selling as much as a 25% stake.The report noted that the talks were ongoing and that the size of the IPO or the possible timing of the offering could change.&nbsp;In early 2025, as part of a plan to save costs, the company planned to shut down around 50 retail locations and shift certain international markets to a distributor model. The firm is home to several premium brands such as Fossil Watches and Michele.&nbsp;<a href="https://stocktwits.com/symbol/VERI">Shares of Fossil Group</a> have jumped 125% this year and gained nearly 213% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/alibaba-executive-reportedly-says-company-beginning-to-see-return-on-ai-investment-in-e-commerce/ch6pRcFR3nf">Alibaba Executive Reportedly Says Company Beginning To See Return On AI Investment In E-Commerce: Forecasts ‘Very Significant’ Positive Impact</a>

Sign of Fossil Group outside a store in Orlando, Florida.

FOSL Stock Plunges After Extending Exchange Offer For Its Senior Notes Due 2026

Separately, the company stated that it is not currently pursuing an initial public offering of its subsidiary in India, following recent media reports about the subsidiary going public.

Equity

Shares of Ovid Therapeutics Inc. (OVID) jumped 18% in the pre-market session on Friday after the company announced positive results from an early-stage trial of its OV329, as well as the pricing of a $175 million placement.OV329 is being developed for the potential treatment of rare and treatment-resistant forms of epilepsy and seizures. It is believed to work by reducing the activity of GABA-AT, an enzyme that degrades GABA, an important inhibitory neurotransmitter in the brain. An increase in levels of GABA in the brain can potentially suppress neuronal hyperexcitability, known to cause seizures, the company said.The early-stage <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.ovidrx.com/news/news-details/2025/Ovid-announces-positive-topline-results-for-the-next-generation-GABA-aminotransferase-inhibitor-OV329-that-demonstrate-strong-inhibitory-activity-and-a-potential-best-in-category-safety-profile/default.aspx">study</a>, which enrolled 68 healthy volunteers, was aimed at evaluating the safety, tolerability, pharmacokinetic, and pharmacodynamic activity of OV329. The drug demonstrated statistically significant inhibition of GABA-AT, matching or exceeding the inhibition demonstrated by therapeutic doses of first-generation GABA-AT inhibitor Vigabatrin (VGB), the company said. The drug also demonstrated a favorable safety and tolerability profile, it added. &nbsp;The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures. The study is expected to start in Q2 2026 and be completed in mid-2027.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/OVID">OVID stock</a> stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:576/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_8_04_20_AM_png_cfbcdadc7f.webp" alt="OVID's Sentiment Meter and Message Volume as of 8:04 a.m. ET on Oct. 03, 2025 | Source: Stocktwits" width="576" height="60"><figcaption>OVID's Sentiment Meter and Message Volume as of 8:04 a.m. ET on Oct. 03, 2025 | Source: Stocktwits</figcaption></figure>Separately, Ovid on Friday also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.ovidrx.com/news/news-details/2025/Ovid-Therapeutics-Announces-Pricing-of-Private-Placement-Totaling-up-to-175-Million-in-Gross-Proceeds/default.aspx">announced</a> the pricing of a private placement totaling up to $175 million in proceeds. The financing transaction included participation from new investors alongside existing ones, the company said.The company stated that it intends to utilize the net proceeds from the initial closing of the financing deal, in conjunction with its existing cash, cash equivalents, and marketable securities, to fund research and development, general corporate expenses, and working capital requirements. It added that it expects its cash to fund its operating plan into 2028.A Stocktwits user applauded the funding news as “huge.”<stembedurl>https://stocktwits.com/Skeetz99/message/630905995</stembedurl>OVID stock is up 76% this year and approximately 45% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/esperion-shares-rally-after-patent-litigation-settlement-for-cholestrol-drugs/chCujWhR3Qb">Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why

The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures.

Eastman Kodak Co. (KODK) experienced a 366% surge in Stocktwits retail chatter in the last 24 hours after the photographic film products maker announced on the X platform that it is making a major move to strengthen pharmaceutical manufacturing within the U.S.&nbsp;&nbsp;<figure class="image"><img style="aspect-ratio:587/183;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_24_082242_png_3c927c29c7.webp" alt="Screenshot 2025-07-24 082242.png" width="587" height="183"></figure>A Stocktwits user said it is the ‘Kodak Moment’ for the company.<stembedurl>https://stocktwits.com/ScottBrownMBA/message/622209783</stembedurl>Another user expressed optimism, linking the news to the U.S. Japan trade deal.<stembedurl>https://stocktwits.com/Zorrelak/message/622217804</stembedurl>However, retail sentiment around the stock remained in ‘bearish’ territory with ‘low’ message volume levels.<figure class="image"><img style="aspect-ratio:975/117;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_24_083017_png_ac1c90c79d.webp" alt="KODK’s Sentiment Meter and Message Volume as of 08.30 a.m. ET on July 24, 2025 | Source: Stocktwits" width="975" height="117"><figcaption>KODK’s Sentiment Meter and Message Volume as of 08.30 a.m. ET on July 24, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/KODK">Eastman Kodak stock</a> inched 0.5% higher in Thursday’s premarket.Kodak ventured into pharmaceuticals after the company was awarded a $765 million federal loan in 2020, aimed at producing pharmaceutical ingredients, as part of a broader effort during the pandemic to strengthen the nation’s medical supply chain.In May of this year, CEO Jim Continenza stated that the company is retrofitting a facility at Eastman Business Park and has committed $20 million to expand U.S. manufacturing, according to a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://rbj.net/2025/05/09/kodak-invests-20m-in-rochester-pharma-manufacturing-expansion/?utm_source=chatgpt.com">report</a> from the&nbsp;Rochester Business Journal.&nbsp;In the first quarter (Q1), the company’s revenue declined 1% year-on-year (YoY) to $243 million.&nbsp;“The group’s new cGMP manufacturing facility, which we expect to be online later this year, will expand our current pharma business into manufacturing FDA-regulated diagnostic test reagents. Our investment in the new pharma facility is just one example of our commitment to investing in U.S.-based manufacturing,” said&nbsp;Continenza after the Q1 earnings.As it evolves into pharmaceuticals, Kodak continues to support its traditional film operations and printing systems, including high-speed inkjet technology.Eastman Kodak stock has gained over 8% year-to-date and over 25% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/alphabet-manhattan-associates-at-and-t-draw-heavy-retail-chatter-on-stocktwits/ch8yupaR5HI">Alphabet, Manhattan Associates, AT&amp;T Draw Heavy Retail Chatter On Stocktwits Among Tech Stocks: More Details Inside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Eastman Kodak Company logo is seen displayed on a smartphone screen.

A Kodak ‘Moment’? Company’s Pharma Expansion Plans Ignite 366% Surge In Retail Chatter

Kodak ventured into pharmaceuticals after the company was awarded a $765 million federal loan in 2020, aimed at producing pharmaceutical ingredients, as part of a broader effort during the pandemic to strengthen the nation’s medical supply chain.

Diversified Energy (DEC) stock gained in pre-market trade on Monday after the company said it would buy Maverick Natural Resources from private equity firm EIG for $1.28 billion.The deal, expected to close in the first half of 2025, would increase the share of oil in Diversified Energy’s total energy production mix.The energy firm said the deal would help nearly double its revenue, and the combined company would have a total production of about 200,000 barrels of oil equivalent per day.The overwhelming majority of Maverick’s production comes from the Western Anadarko Basin, the Ark-La-Tex region of East Texas, and the largest U.S. shale oilfield Permian Basin.Over the past one and half years, the Permian has been a focal point of deal activity in the U.S. due to its robust infrastructure and relatively lower production costs.<a href="https://stocktwits.com/symbol/DEC">Diversified Energy</a> said EIG would own 20% of the combined company once the transaction closes.Rusty Hutson, the CEO of Diversified Energy, will continue to serve in his position after the deal is completed.“The acquired producing assets have demonstrated leading well performance and are a natural fit with our operating advantage and existing acreage,” Hutson said.The company said it is liable to pay $50 million in termination fees under certain circumstances.Retail sentiment on Stocktwits jumped to ‘extremely bullish’ (96/100) territory from ‘bearish’(36/100) a day ago, while retail chatter remained ‘extremely high’.<figure class="image"><img style="aspect-ratio:886/206;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/DEC_Jan_27_e4c793b801.JPG" alt="DEC’s Sentiment Meter and Message Volume as of 08:20 a.m. ET on Jan. 27, 2025 | Source: Stocktwits" width="886" height="206"><figcaption>DEC’s Sentiment Meter and Message Volume as of 08:20 a.m. ET on Jan. 27, 2025 | Source: Stocktwits</figcaption></figure>Earlier this month, Diversified Energy had agreed to buy some natural gas assets from Summit Natural Resources for $45 million.Over the past year, the stock has gained 32.5%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/super-micro-stock-crashes-below-30-support-premarket/chbkvyQRov">Super Micro Stock Crashes Below $30 Support Premarket As DeepSeek Fears Rattle AI Stocks: Retail Sentiment Mixed</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

An oil pumpjack in a field on March 24, 2024 in Grandfalls, Texas. (Photo by Brandon Bell/Getty Images)

Diversified Energy Stock Rises After Deal To Buy Maverick Natural Resources for $1.28B: Retail’s Elated

The deal, expected to close in the first half of 2025, would increase the share of oil in Diversified Energy’s total energy production mix.

EA Series Trust - EA Bridgeway Omni Small-Cap Value ETF

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$22.44
Prev Close	$22.30
Open	$22.24
Dividend Yield	N/A
50-Day Moving Average	$22.65
Beta	N/A
Avg. Volume	151,823.74
PE Ratio	N/A

52-Week High	$24.22
52-Week Low	$16.55
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

BSVO
EA Series Trust - EA Bridgeway Omni Small-Cap Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest BSVO News

BSVOEA Series Trust - EA Bridgeway Omni Small-Cap Value ETF